Stay updated on Durvalumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov version as v3.7.1 instead of v3.7.0; the study record content is unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry v3.7.0 is added to the record history and the older revision v3.6.6 is removed from the list, updating the page's version history.SummaryDifference0.1%

- Check33 days agoChange DetectedA new history entry is added for version 34 dated 2026-08-18 and a Study Status update appears on 2026-09-11. An older 2026-05-01 entry was removed, reflecting an updated history of the study record.SummaryDifference0.3%

- Check46 days agoChange DetectedThe page history now displays Revision: v3.6.6 instead of v3.6.5, signaling a new revision of the study record in the history log.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor metadata update to the study record history.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now displays the site revision as v3.6.4, replacing v3.6.3. This appears to be a minor platform update that does not alter study information visible to users.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.